Enoxaparin pharmacokinetics and pharmacodynamics in renal impairment

被引：0
|
作者：
Sanderink, GJ
Guimart, C
Jariwala, N
Shukla, U
Ozoux, ML
Boutouyrie, B
Hutman, HW
Gutierrez, M
Marbury, T
Preston, R
机构：
[1] Aventis Pharma, Antony, France
[2] Invest Grp, Miami, FL USA
[3] Invest Grp, Orlando, FL USA
[4] Invest Grp, Ft Lauderdale, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2001年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229A / 229A
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment
    Venkatakrishnan, Karthik
    Liu, Yi
    Noe, Dennis
    Mertz, Jaime
    Bargfrede, Michael
    Marbury, Thomas
    Farbakhsh, Kambiz
    Oliva, Cristina
    Milton, Ashley
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (06) : 986 - 997
  • [22] Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran
    Eriksson, UG
    Johansson, S
    Attman, PO
    Mulec, H
    Frison, L
    Fager, G
    Samuelsson, O
    CLINICAL PHARMACOKINETICS, 2003, 42 (08) : 743 - 753
  • [23] Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease
    Small, D. S.
    Wrishko, R. E.
    Ernest, C. S., II
    Ni, L.
    Winters, K. J.
    Farid, N. A.
    Li, Y. G.
    Brandt, J. T.
    Salazar, D. E.
    Borel, A. G.
    Kles, K. A.
    Payne, C. D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (05) : 585 - 594
  • [24] PHARMACOKINETICS OF ENOXAPARIN IN PEDIATRIC RENAL TRANSPLANTATION
    Alice, Damamme
    Saik, Urien
    Remi, Salomon
    Dominique, Lasne
    Pauline, Krug
    Marina, Charbit
    Jean-marc, Treluyer
    Olivia, Boyer
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1675 - 1676
  • [25] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT SOLUBLE THROMBOMODULIN IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WITH RENAL IMPAIRMENT
    Hayakawa, Mineji
    Yamamoto, Hiroshi
    Honma, Taeko
    Mukai, Nobutaka
    Higashiyama, Asumi
    Sugano, Masahiro
    Kubota, Nobuhiko
    Uegaki, Shinji
    Sawamura, Atsushi
    Gando, Satoshi
    SHOCK, 2012, 37 (06): : 569 - 573
  • [26] The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: A prospective dose adjustment study
    Lichtman, SM
    Etcubanas, E
    Budman, DR
    Eisenberg, P
    Zervos, G
    D'Amico, P
    O'Mara, V
    Musgrave, K
    Cascella, P
    Melikian, A
    Hinderling, PH
    Ferrer, JM
    Williams, GJ
    CANCER INVESTIGATION, 2002, 20 (7-8) : 904 - 913
  • [27] Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor
    William B. Smith
    Jesse Hall
    Jolene K. Berg
    Michal Kazimir
    Amy Yamamoto
    Susan Walker
    Caroline A. Lee
    Zancong Shen
    David M. Wilson
    Dongmei Zhou
    Michael Gillen
    Thomas C. Marbury
    Clinical Drug Investigation, 2018, 38 : 703 - 713
  • [28] The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
    Sahasrabudhe, V.
    Terra, S. G.
    Hickman, A.
    Saur, D.
    Shi, H.
    O'Gorman, M.
    Zhou, Z.
    Cutler, D. L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1432 - 1443
  • [29] EFFECTS OF VARIOUS DEGREES OF RENAL IMPAIRMENT AND HEMODIALYSIS ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INCB018424.
    Shi, J.
    Chen, X.
    McGee, R.
    Landman, R.
    Lo, Y.
    Emm, T.
    Scherle, P.
    Bowman, J.
    Punwani, N.
    Williams, W.
    Yeleswaram, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S84 - S84
  • [30] Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor
    Smith, William B.
    Hall, Jesse
    Berg, Jolene K.
    Kazimir, Michal
    Yamamoto, Amy
    Walker, Susan
    Lee, Caroline A.
    Shen, Zancong
    Wilson, David M.
    Zhou, Dongmei
    Gillen, Michael
    Marbury, Thomas C.
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 703 - 713
12345